Vor Biopharma Inc. (VOR) Social Stream
VOR BIOPHARMA INC (VOR) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering VOR.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-10-19 | 5 | $60 | $40 | $51 | $2.85 | 1689.47% |
| 2021-11-15 | 5 | $60 | $40 | $50.8 | $2.85 | 1682.46% |
| 2021-12-02 | 7 | $60 | $30 | $47.333 | $2.85 | 1560.81% |
| 2021-12-03 | 7 | $60 | $30 | $46 | $2.85 | 1514.04% |
| 2021-12-17 | 8 | $60 | $26 | $43.5 | $2.85 | 1426.32% |
| 2022-01-21 | 8 | $56 | $26 | $41.75 | $2.85 | 1364.91% |
| 2022-03-15 | 6 | $46 | $26 | $34.333 | $2.85 | 1104.67% |
| 2022-05-13 | 7 | $46 | $6 | $30.285 | $2.85 | 962.63% |
| 2022-05-16 | 7 | $38 | $6 | $24 | $2.85 | 742.11% |
| 2022-05-24 | 7 | $38 | $4 | $23.714 | $2.85 | 732.07% |
| 2022-08-12 | 7 | $38 | $4 | $21.285 | $2.85 | 646.84% |
| 2022-08-15 | 7 | $38 | $4 | $20.428 | $2.85 | 616.77% |
| 2022-10-24 | 6 | $38 | $4 | $20.428 | $2.85 | 616.77% |
| 2022-11-14 | 7 | $38 | $4 | $18.125 | $2.85 | 535.96% |
| 2023-03-23 | 6 | $20 | $4 | $15.285 | $2.85 | 436.32% |
| 2023-03-24 | 8 | $18 | $4 | $14.785 | $2.85 | 418.77% |
| 2023-05-16 | 8 | $22 | $4 | $14.687 | $2.85 | 415.33% |
| 2023-08-11 | 7 | $22 | $10 | $16.214 | $2.85 | 468.91% |
| 2023-11-10 | 7 | $22 | $10 | $15.071 | $2.85 | 428.81% |
The Trend in the Analyst Price Target
VOR's average price target has moved down $0.21 over the prior 48 weeks.
Over the past 38 weeks, VOR's average upside potential has been 412.89%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-08-11 | 7 | 22 | 10.0 | 16.214 | 2.94 | 451.5% |
| 2023-11-09 | 7 | 22 | 10.0 | 15.071 | 1.86 | 710.27% |
| 2023-11-10 | 7 | 22 | 10.0 | 15.071 | 1.76 | 756.31% |
| 2023-11-10 | 8 | 22 | 10.0 | 15.071 | 1.76 | 756.31% |
| 2023-11-10 | 8 | 22 | 4.5 | 13.750 | 1.76 | 681.25% |
VOR Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1 | 7 | 0 | 0 | 0 | 0 | 7 |
The Trend in the Broker Recommendations
Over the past 13 months, VOR's average broker recommendation rating improved by 0.33.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for VOR as an investment opportunity.
- To contextualize these metrics, consider that out of all US stocks, VOR BIOPHARMA INC's upside potential (average analyst target price relative to current price) is greater than 2780.91% of them.
- VOR BIOPHARMA INC's variance in analysts' estimates is lower than -2296.19% of all US stocks.
- In terms of how VOR BIOPHARMA INC fares relative to stocks in the small market cap category, note that its number of analysts covering the stock is higher than 2316.3% of that group.
- In terms of how VOR BIOPHARMA INC fares relative to stocks in the small market cap category, note that its average analyst price target is higher than 1881.4% of that group.
Stocks similar to VOR BIOPHARMA INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are FNCH, IKNA, and ACHL.
View All Top Stocks by Price Target
Make investment decisions regarding VOR using the data that counts. Try POWR Ratings for free.